References
- Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-407. https://doi.org/10.1056/NEJM197502202920807
- Stertz G. Polymyositis. Berl Klin Wochenschr 1916;53:489.
- Hsu JL, Liao MF, Chu CC, et al. Reappraisal of the incidence, various types and risk factors of malignancies in patients with dermatomyositis and polymyositis in Taiwan. Sci Rep 2021;11:4545. https://doi.org/10.1038/s41598-021-83729-5
- Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001;357:96-100. https://doi.org/10.1016/S0140-6736(00)03540-6
- Lee SW, Jung SY, Park MC, Park YB, Lee SK. Malignancies in Korean patients with inflammatory myopathy. Yonsei Med J 2006;47:519-523. https://doi.org/10.3349/ymj.2006.47.4.519
- Yang SY, Cha BK, Kim G, et al. Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma. Korean J Intern Med 2014;29:231-235. https://doi.org/10.3904/kjim.2014.29.2.231
- Yang Z, Lin F, Qin B, Liang Y, Zhong R. Polymyositis/ dermatomyositis and malignancy risk: a metaanalysis study. J Rheumatol 2015;42:282-291. https://doi.org/10.3899/jrheum.140566
- Liu Y, Xu L, Wu H, et al. Characteristics and predictors of malignancy in dermatomyositis: analysis of 239 patients from Northern China. Oncol Lett 2018;16:5960-5968. https://doi.org/10.3892/ol.2018.9409
- Syrios J, Kechagias G, Xynos ID, et al. Pancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: case report. BMC Gastroenterol 2011;11:33. https://doi.org/10.1186/1471-230X-11-33
- Park JE, Kang T, Yoo JS, Lee HS. A case of dermatomyositis in a patient with a neuroendocrine tumor at the ampulla of vater. Korean J Med 2017;92:552-557. https://doi.org/10.3904/kjm.2017.92.6.552
- Aggarwal R, Oddis CV. Therapeutic advances in myositis. Curr Opin Rheumatol 2012;24:635-641. https://doi.org/10.1097/BOR.0b013e328358ac72
- Cherin P, Pelletier S, Teixeira A, et al. Results and longterm followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients. Arthritis Rheum 2002;46:467-474. https://doi.org/10.1002/art.10053
- Dias LP, Faria AL, Scandiuzzi MM, Inhaia CL, Shida JY, Gebrim LH. A rare case of severe myositis as paraneoplastic syndrome on breast cancer. World J Surg Oncol 2015;13:134. https://doi.org/10.1186/s12957-015-0534-5
- Ernste FC, Reed AM. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations. Mayo Clin Proc 2013;88:83-105. https://doi.org/10.1016/j.mayocp.2012.10.017
- Walker UA. Imaging tools for the clinical assessment of idiopathic inflammatory myositis. Curr Opin Rheumatol 2008;20:656-661. https://doi.org/10.1097/BOR.0b013e3283118711
- Yao L, Yip AL, Shrader JA, et al. Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies. Rheumatology (Oxford) 2016;55:441-449. https://doi.org/10.1093/rheumatology/kev344